These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21454498)

  • 1. Structural study of the complex stereoselectivity of human butyrylcholinesterase for the neurotoxic V-agents.
    Wandhammer M; Carletti E; Van der Schans M; Gillon E; Nicolet Y; Masson P; Goeldner M; Noort D; Nachon F
    J Biol Chem; 2011 May; 286(19):16783-9. PubMed ID: 21454498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Productive reorientation of a bound oxime reactivator revealed in room temperature X-ray structures of native and VX-inhibited human acetylcholinesterase.
    Gerlits O; Kong X; Cheng X; Wymore T; Blumenthal DK; Taylor P; Radić Z; Kovalevsky A
    J Biol Chem; 2019 Jul; 294(27):10607-10618. PubMed ID: 31138650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantioseparation, in vitro testing, and structural characterization of triple-binding reactivators of organophosphate-inhibited cholinesterases.
    Maraković N; Knežević A; Rončević I; Brazzolotto X; Kovarik Z; Šinko G
    Biochem J; 2020 Aug; 477(15):2771-2790. PubMed ID: 32639532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivation of organophosphate-inhibited serum butyrylcholinesterase by novel substituted phenoxyalkyl pyridinium oximes and traditional oximes.
    Nichols RH; Chambers JE
    Toxicology; 2021 Mar; 452():152719. PubMed ID: 33592259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo toxicological studies of V nerve agents: molecular and stereoselective aspects.
    Reiter G; Müller S; Hill I; Weatherby K; Thiermann H; Worek F; Mikler J
    Toxicol Lett; 2015 Jan; 232(2):438-48. PubMed ID: 25448275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical synthesis of two series of nerve agent model compounds and their stereoselective interaction with human acetylcholinesterase and human butyrylcholinesterase.
    Barakat NH; Zheng X; Gilley CB; MacDonald M; Okolotowicz K; Cashman JR; Vyas S; Beck JM; Hadad CM; Zhang J
    Chem Res Toxicol; 2009 Oct; 22(10):1669-79. PubMed ID: 19715346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kinetic and molecular docking analysis of interactions between three V-type nerve agents and four human cholinesterases.
    Li K; Liu Y; Liu Y; Li Q; Guo L; Xie J
    Chem Biol Interact; 2023 Feb; 372():110369. PubMed ID: 36708975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition pathways of the potent organophosphate CBDP with cholinesterases revealed by X-ray crystallographic snapshots and mass spectrometry.
    Carletti E; Colletier JP; Schopfer LM; Santoni G; Masson P; Lockridge O; Nachon F; Weik M
    Chem Res Toxicol; 2013 Feb; 26(2):280-9. PubMed ID: 23339663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Insights of Stereospecific Inhibition of Human Acetylcholinesterase by VX and Subsequent Reactivation by HI-6.
    Bester SM; Guelta MA; Cheung J; Winemiller MD; Bae SY; Myslinski J; Pegan SD; Height JJ
    Chem Res Toxicol; 2018 Dec; 31(12):1405-1417. PubMed ID: 30462502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of AChE active site gorge in determining stereoselectivity of charged and noncharged VX enantiomers.
    Ordentlich A; Barak D; Sod-Moriah G; Kaplan D; Mizrahi D; Segall Y; Kronman C; Karton Y; Lazar A; Marcus D; Velan B; Shafferman A
    Chem Biol Interact; 2005 Dec; 157-158():191-8. PubMed ID: 16289014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of V agents and V-analogue compounds to probe the active site of atypical butyrylcholinesterase from Oryzias latipes.
    Kirkpatrick MG; diTargiani RC; Sweeney RE; Otto TC
    Chem Biol Interact; 2016 Nov; 259(Pt B):182-186. PubMed ID: 27000540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
    Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
    Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
    Bartling A; Worek F; Szinicz L; Thiermann H
    Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Butyrylcholinesterase inhibited by nerve agents is efficiently reactivated with chlorinated pyridinium oximes.
    Zorbaz T; Malinak D; Kuca K; Musilek K; Kovarik Z
    Chem Biol Interact; 2019 Jul; 307():16-20. PubMed ID: 31004594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
    Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
    Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of high-affinity phenyltetrahydroisoquinoline aldoximes, linked through anti-triazoles, as reactivators of phosphylated cholinesterases.
    Maček Hrvat N; Kalisiak J; Šinko G; Radić Z; Sharpless KB; Taylor P; Kovarik Z
    Toxicol Lett; 2020 Mar; 321():83-89. PubMed ID: 31863869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyridoxal oxime derivative potency to reactivate cholinesterases inhibited by organophosphorus compounds.
    Bušić V; Katalinić M; Šinko G; Kovarik Z; Gašo-Sokač D
    Toxicol Lett; 2016 Nov; 262():114-122. PubMed ID: 27693733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic-site conformational equilibrium in nerve-agent adducts of acetylcholinesterase: possible implications for the HI-6 antidote substrate specificity.
    Artursson E; Andersson PO; Akfur C; Linusson A; Börjegren S; Ekström F
    Biochem Pharmacol; 2013 May; 85(9):1389-97. PubMed ID: 23376121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytic Detoxification of Organophosphorus Nerve Agents by Butyrylcholinesterase-Polymer-Oxime Bioscavengers.
    Zhang L; Murata H; Amitai G; Smith PN; Matyjaszewski K; Russell AJ
    Biomacromolecules; 2020 Sep; 21(9):3867-3877. PubMed ID: 32786529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation of human acetylcholinesterase and butyrylcholinesterase inhibited by leptophos-oxon with different oxime reactivators in vitro.
    Jun D; Musilova L; Pohanka M; Jung YS; Bostik P; Kuca K
    Int J Mol Sci; 2010 Aug; 11(8):2856-63. PubMed ID: 21152278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.